#USA #Boston #Mayo Clinic #Cognitive Care #Neuroglee Health

Neuroglee Health Expands Collaboration with Mayo Clinic for At-Home Dementia Solutions

In a significant advancement in the field of dementia care, Neuroglee Health has announced an expanded partnership with the renowned Mayo Clinic. This collaboration aims to deliver comprehensive at-home cognitive and dementia care solutions, ensuring patients and their caregivers receive the personalized support they need. The initiative arises from a previously established relationship focusing on the Neuroglee Connect™ solution, which emphasizes the principles from the HABIT (Healthy Action to Benefit Independence & Thinking) program. This program is designed to provide patients and their families with access to leading treatments, fundamentally promoting cognitive function and independence, especially for those diagnosed with Mild Cognitive Impairment (MCI).

Neuroglee Health specializes in value-based dementia care, combining technology with high-touch support to ensure each patient receives individualized care. Under this newly expanded initiative, patients suffering from cognitive impairments and dementia can enroll in a structured program. This program provides longitudinal virtual care, managed by a dedicated team that includes advanced practice nurses, social workers, pharmacists, and care navigators, all supervised by specialists in neurology and geriatric psychiatry. This structure allows for round-the-clock, high-quality care tailored to the specific needs of patients.

One of the key highlights of Neuroglee’s approach is its focus on care partners, recognizing the essential role they play in the patient’s journey. As dementia progresses, the program is designed to support not only the patients but also their caregivers, ensuring that they are equipped to handle the emotional and practical challenges that arise. This whole-person approach emphasizes maintaining continuity in home care and avoiding unnecessary hospital visits, ultimately improving both outcomes and minimizing costs through proactive symptom management, efficient testing, diagnosis, and remote monitoring.

Aniket Singh Rajput, the Founder and CEO of Neuroglee, stated, “Our clinically proven, technology-enhanced care model leverages Mayo Clinic's expertise to deliver individualized long-term support for both patients and their caregivers.” He added that this expanded collaboration marks a significant milestone in Neuroglee’s mission to lower the overall cost of dementia care while enhancing accessibility and quality of life for families experiencing cognitive decline.

The implications of their partnership are far-reaching, especially as Neuroglee has been selected for the Center for Medicare & Medicaid Innovation's GUIDE (Guiding an Improved Dementia Experience) Model. This initiative represents a pioneering effort to provide value-based dementia care to Medicare beneficiaries. Neuroglee will enroll eligible participants at no cost to the patients or their families across various Mayo Clinic locations and additional partner sites.

Dementia can impose heavy financial burdens, with the average annual per-member cost for Medicare surpassing $22,000 for individuals with dementia—approximately three times higher than that for those without Alzheimer’s or other forms of dementia. However, through Neuroglee’s comprehensive and forward-thinking care model, it is projected that payers can save over $6,300 per member per year by facilitating early detection and comprehensive ongoing care. This economic benefit stems from Neuroglee's tailored approach accommodating the patient's needs and cognitive stage, focusing initially on patient-centric support and gradually transitioning to empower care partners as the condition evolves.

Neuroglee’s commitment to performance-driven healthcare through strategic partnerships and innovative care delivery models is reshaping the landscape of cognitive care. As this momentum grows, backed by national programs and an increasing engagement with payers, Neuroglee is poised to redefine dementia care, ensuring that patients and their families receive the right support throughout every phase of this challenging journey.

About Neuroglee Health

Neuroglee Health is a pioneering organization specializing in value-based comprehensive dementia care. The company integrates a technology-enabled platform with a highly skilled interdisciplinary care team trained in cognitive and dementia care, providing unparalleled support for individuals, care partners, and families from the early stages of Mild Cognitive Impairment through end-stage dementia. By partnering with healthcare systems, payers, and risk-bearing entities, Neuroglee Health seeks to improve patient outcomes, reduce unnecessary healthcare expenditures, and deliver dementia care that prioritizes personalized and proactive solutions.